Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Herr, I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Herr, I; Debatin, KM
      Cellular stress response and apoptosis in cancer therapy

      BLOOD
    2. Herr, I; Posovsky, C; Bohler, T; Debatin, KM
      mAb 33 from Transduction Laboratories specifically binds to human CD95-L

      CELL DEATH AND DIFFERENTIATION
    3. Herr, I; Posovszky, C; Di Marzio, L; Cifone, MG; Boehler, T; Debatin, KM
      Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha

      ONCOGENE
    4. Herr, I; Krilleke, D; Debatin, KM
      A sensitive, non-radioactive and fast method for detection of JNK/SAPK activity in leukemic T cells

      LEUKEMIA
    5. Kolbus, A; Herr, I; Schreiber, M; Debatin, KM; Wagner, EF; Angel, P
      c-Jun-dependent CD95-L expression is a rate-limiting step in the inductionof apoptosis by alkylating agents

      MOLECULAR AND CELLULAR BIOLOGY
    6. Bernassola, F; Scheuerpflug, C; Herr, I; Krammer, PH; Debatin, KM; Melino, G
      Induction of apoptosis by IFN gamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit

      CELL DEATH AND DIFFERENTIATION
    7. Herr, I; Wilhelm, D; Meyer, E; Jeremias, I; Angel, P; Debatin, KM
      JNK/SAPK activity contributes to TRAIL-induced apoptosis

      CELL DEATH AND DIFFERENTIATION
    8. Posovszky, C; Friesen, C; Herr, I; Debatin, KM
      Chemotherapeutic drugs sensitize pre-E ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis

      LEUKEMIA
    9. Martin-Villalba, A; Herr, I; Jeremias, I; Hahne, M; Brandt, R; Vogel, J; Schenkel, J; Herdegen, T; Debatin, KM
      CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons

      JOURNAL OF NEUROSCIENCE
    10. Herr, I; Wilhelm, D; Bohler, T; Angel, P; Debatin, KM
      JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, trail and TNF-alpha

      INTERNATIONAL JOURNAL OF CANCER
    11. Herr, I; Martin-Villalba, A; Kurz, E; Roncaioli, P; Schenkel, J; Cifone, MG; Debatin, KM
      FK506 prevents stroke-induced generation of ceramide and apoptosis signaling

      BRAIN RESEARCH
    12. MARTINVILLALBA A; HERR I; JEREMIAS I; DEBATIN KM; HERDEGEN T; WINTER C; SCHENKEL J; ZIMMERMANN M
      ISCHEMIA-INDUCED APOPTOSIS IN THE ADULT BRAIN CRITICALLY DEPENDS ON THE EXPRESSION OF CD95-L, TRAIL, TNF-ALPHA AND C-JUN

      European journal of neuroscience
    13. JEREMIAS I; HERR I; BOEHLER T; DEBATIN KM
      TRAIL APO-2-LIGAND-INDUCED APOPTOSIS IN HUMAN T-CELLS/

      European Journal of Immunology
    14. JEREMIAS I; KUPATT C; BAUMANN B; HERR I; WIRTH T; DEBATIN KM
      INHIBITION OF NUCLEAR FACTOR KAPPA-B ACTIVATION ATTENUATES APOPTOSIS RESISTANCE IN LYMPHOID-CELLS

      Blood
    15. BOHLER T; BAUMLER C; HERR I; GROLL A; KURZ M; DEBATIN KM
      ACTIVATION OF THE CD95 SYSTEM INCREASES WITH DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED CHILDREN AND ADOLESCENTS

      The Pediatric infectious disease journal
    16. ARTS J; HERR I; LANSINK M; ANGEL P; KOOISTRA T
      CELL-TYPE-SPECIFIC DNA-PROTEIN INTERACTIONS AT THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR PROMOTER IN HUMAN ENDOTHELIAL AND HELA-CELLS IN-VIVO AND IN-VITRO

      Nucleic acids research
    17. DEBATIN KM; BELTINGER C; BOHLER T; FELLENBERG J; FRIESEN C; FULDA S; HERR I; LOS M; SCHEUERPFLUG C; SIEVERTS H; STAHNKE K
      REGULATION OF APOPTOSIS THROUGH CD95 (APO-I FAS) RECEPTOR-LIGAND INTERACTION/

      Biochemical Society transactions
    18. HERR I; WILHELM D; BOHLER T; ANGEL P; DEBATIN KM
      ACTIVATION OF CD95 (APO-1 FAS) SIGNALING BY CERAMIDE MEDIATES CANCER THERAPY-INDUCED APOPTOSIS/

      EMBO journal
    19. FULDA S; SIEVERTS H; FRIESEN C; HERR I; DEBATIN KM
      THE CD95 (APO-1 FAS) SYSTEM MEDIATES DRUG-INDUCED APOPTOSIS IN NEUROBLASTOMA-CELLS/

      Cancer research
    20. LOS M; HERR I; FRIESEN C; FULDA S; SCHULZEOSTHOFF K; DEBATIN KM
      CROSS-RESISTANCE OF CD95-INDUCED AND DRUG-INDUCED APOPTOSIS AS A CONSEQUENCE OF DEFICIENT ACTIVATION OF CASPASES (ICE CED-3 PROTEASES)/

      Blood
    21. BOHLER T; HERR I; DEBATIN KM; GEISS M; HAAS J
      DOWN-REGULATION OF INCREASED CD95 (APO-1 FAS) LIGAND IN T-CELLS FROM HUMAN IMMUNODEFICIENCY VIRUS-TYPE 1-INFECTED CHILDREN AFTER ANTIRETROVIRAL THERAPY/

      Blood
    22. BOHLER T; WALCHER J; HOLZLWENIG G; HERR I; DEBATIN KM
      SHORT-TERM EFFECT OF ANTIRETROVIRAL THERAPY ON DYSREGULATION OF THE CD95 (APO-1 FAS) SYSTEM AND T-CELL HOMEOSTASIS IN HIV-1-INFECTED CHILDREN AND ADOLESCENTS/

      Blood
    23. HERR I; BOHLER T; WILHELM D; ANGEL P; DEBATIN KM
      ACTIVATION OF THE CD95 (APO-1 FAS) PATHWAY BY CERAMIDE MEDIATES RADIOTHERAPY AND CHEMOTHERAPY-INDUCED APOPTOSIS/

      Blood
    24. HERR I; BALEMANS L; BOHLER T; WALCZAK H; DEBATIN KM
      MONITORING OF CD95 (APO-1 FAS) LIGAND EXPRESSION IN HUMAN T-CELLS BY QUANTITATIVE RT-PCR/

      Cell death and differentiation
    25. FRIESEN C; HERR I; KRAMMER PH; DEBATIN KM
      INVOLVEMENT OF THE CD95 (APO-1 FAS) RECEPTOR/LIGAND SYSTEM IN DRUG-INDUCED APOPTOSIS IN LEUKEMIA-CELLS/

      Nature medicine
    26. EHRET A; WESTENDORP MO; HERR I; DEBATIN KM; HEENEY JL; FRANK R; KRAMMER PH
      RESISTANCE OF CHIMPANZEE T-CELLS TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT-ENHANCED OXIDATIVE STRESS AND APOPTOSIS

      Journal of virology
    27. BAUMLER CB; BOHLER T; HERR I; BENNER A; KRAMMER PH; DEBATIN KM
      ACTIVATION OF THE CD95 (APO-1 FAS) SYSTEM IN T-CELLS FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED CHILDREN/

      Blood
    28. BOHLER T; HERR I; NEDEL S; HECKER S; DEBATIN KM
      INCREASED CD95 (APO-1 FAS) LIGAND IN T-CELLS FROM OLIGO-SYMPTOMATIC HIV-1-INFECTED CHILDREN - DOWN-REGULATION FOLLOWING ANTIRETROVIRAL THERAPY/

      Blood
    29. DEBATIN KM; FRIESEN C; HERR I; LOS M
      ACTIVATION OF THE CD95 PATHWAY BY ANTICANCER DRUGS

      Blood
    30. JUNDT F; HERR I; ANGEL P; ZURHAUSEN H; BAUKNECHT T
      TRANSCRIPTIONAL CONTROL OF HUMAN PAPILLOMAVIRUS TYPE-18 ONCOGENE EXPRESSION IN DIFFERENT CELL-LINES - ROLE OF TRANSCRIPTION FACTOR YY1

      Virus genes
    31. SCHORPP M; MATTEI MG; HERR I; GACK S; SCHAPER J; ANGEL P
      STRUCTURAL ORGANIZATION AND CHROMOSOMAL LOCALIZATION OF THE MOUSE COLLAGENASE TYPE-I GENE

      Biochemical journal
    32. VANDAM H; WILHELM D; HERR I; STEFFEN A; HERRLICH P; ANGEL P
      ATF-2 IS PREFERENTIALLY ACTIVATED BY STRESS-ACTIVATED PROTEIN-KINASESTO MEDIATE C-JUN INDUCTION IN RESPONSE TO GENOTOXIC AGENTS

      EMBO journal
    33. WILHELM D; VANDAM H; HERR I; BAUMANN B; HERRLICH P; ANGEL P
      BOTH ATF-2 AND C-JUN ARE PHOSPHORYLATED BY STRESS-ACTIVATED PROTEIN-KINASES IN RESPONSE TO UV IRRADIATION

      Immunobiology
    34. BAUKNECHT T; JUNDT F; HERR I; OEHLER T; DELIUS H; SHI Y; ANGEL P; ZURHAUSEN H
      A SWITCH REGION DETERMINES THE CELL-TYPE-SPECIFIC POSITIVE OR NEGATIVE ACTION OF YY1 ON THE ACTIVITY OF THE HUMAN PAPILLOMAVIRUS TYPE-18 PROMOTER

      Journal of virology
    35. HERR I; BALEMANS L; FRIESEN C; DEBATIN KM
      DEVELOPMENT OF A QUANTITATIVE RT-PCR FOR THE HUMAN APO-1 (FAS CD95) LIGAND AND MONITORING OF LIGAND EXPRESSION IN NORMAL AND MALIGNANT T-CELLS/

      Blood
    36. DEBATIN KM; BAUMLER C; HERR I; STRICKER K; KNIPPING E; BOHLER T; KRAMMER PH
      INVOLVEMENT OF THE APO-1 (FAS CD95) SYSTEM IN T-CELL DEPLETION IN AIDS/

      Blood
    37. HERR I; VANDAM H; ANGEL P
      BINDING OF PROMOTER-ASSOCIATED AP-1 IS NOT ALTERED DURING INDUCTION AND SUBSEQUENT REPRESSION OF THE C-JUN PROMOTER BY TPA AND UV IRRADIATION

      Carcinogenesis
    38. HAGMEYER BM; KONIG H; HERR I; OFFRINGA R; ZANTEMA A; VANDEREB AJ; HERRLICH P; ANGEL P
      ADENOVIRUS E1A NEGATIVELY AND POSITIVELY MODULATES TRANSCRIPTION OF AP-1 DEPENDENT GENES BY DIMER-SPECIFIC REGULATION OF THE DNA-BINDING AND TRANSACTIVATION ACTIVITIES OF JUN

      EMBO journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 19:45:57